Reaction
Cauda Equina Syndrome reporting signals
As of the last recalculation, Cauda Equina Syndrome appears in 763 FAERS reports alongside 13 co-occurring drug terms. The strongest observed disproportionality signal is BUPIVACAINE (PRR 119.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Bupivacaine | 39 | 119.9 | 120.4 |
| Lidocaine Hydrochloride And Epinephrine Bitartrate | 63 | 35.0 | 35.1 |
| Lidocaine Hydrochloride | 69 | 34.2 | 34.3 |
| Lidicaine | 49 | 29.1 | 29.2 |
| Burn Relief | 49 | 29.1 | 29.2 |
| Lidocaine Hydrochloride And Epinephrine | 49 | 29.1 | 29.1 |
| Lidocaine, Menthol | 49 | 28.7 | 28.8 |
| Lidocaine 4% | 51 | 27.3 | 27.3 |
| Lidocaine | 52 | 26.0 | 26.1 |
| Methylprednisolone Acetate | 7 | 24.1 | 24.1 |
| Durvalumab | 11 | 15.0 | 15.0 |
| Fondaparinux Sodium | 4 | 13.5 | 13.6 |
| Daptomycin | 4 | 11.9 | 11.9 |